Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: A descriptive study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 6, 2011, Pages 682-687

  Ramagopalan, Sreeram V ^a,b,c   Hoang, Uy ^d   Seagroatt, Valerie ^d   Handel, Adam ^a,b   Ebers, George C ^a,b   Giovannoni, Gavin ^c   Goldacre, Michael J ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; INFECTIOUS MONONUCLEOSIS; LENGTH OF STAY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; UNITED KINGDOM;

ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INFECTIOUS MONONUCLEOSIS; LENGTH OF STAY; MALE; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 79955756301     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.232108     Document Type: Article

References (17)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000;343:938-52.
2. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-77. (Pubitemid 351222732)
3. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-91. (Pubitemid 34792722)
4. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-32.
5. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988;1:1-25.
6. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49:1115-24. (Pubitemid 16028692)
7. Forbes RB, Swingler RJ. Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology. Am J Epidemiol 1999;149:1016-24.
8. Compston A, McAlpine D. McAlpine's Multiple Sclerosis. 4th Edn. Philadelphia, PA: Churchill Livingstone/Elsevier, 2005.
9. McCrone P, Heslin M, Knapp M, et al. Multiple sclerosis in the UK: service use, costs, quality of life and disability. Pharmacoeconomics 2008;26:847-60.
10. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006;59:499-503. (Pubitemid 43358070)
11. Ramagopalan SV, Valdar W, Dyment DA, et al. Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 2009;32:257-62.
12. Goldacre MJ, Wotton CJ, Seagroatt V, et al. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 2004;58:1032-5. (Pubitemid 39564205)
13. Russell WR. Multiple sclerosis: occupation and social group at onset. Lancet 1971;2:832-4.
14. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288-99.
15. Ahlgren C, Toren K, Oden A, et al. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 2009;24:541-52.
16. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599-612.
17. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-8. (Pubitemid 27489217)